News dal mondo
21
Mar
EU pharmaceutical policy: MEPs support comprehensive reform
MEPs adopted their proposals to revamp EU pharmaceutical legislation, to foster innovation and enhance...
20
Riforma farmaceutica: il Parlamento Ue non tocca (quasi) i tempi della tutela regolatoria
Nuovo codice del farmaco europeo: il Parlamento Ue potrebbe accettare di estendere a 7,5 anni la tutela...
15
US FDA Final Guidance: Controlled Correspondence Related to Generic Drug Development
FDA is committed to ensuring current and prospective abbreviated new drug application (ANDA) applicants...
FDA publishes artificial intelligence paper
FDA published its new paper, “Artificial Intelligence and Medical Products: How CBER, CDER, CDRH,...
le ultime news
29 Gen
US FDA Issues Revised Draft Guidance on Remote Regulatory Assessments
26 Gen
First court judgment on SPC manufacturing waiver alarms off-patent drugmakers
European Council clears EMA to overhaul its fee system to ensure adequate funding
24 Gen
EMA Revised Drugmaker User Guide for Small, Medium Companies Released
FDA's ISTAND Pilot Program accepts submission of first artificial intelligence-based and digital health technology for neuroscience
European Commission adopts first European positive lists for drinking water
US FDA Draft Guidance on Good Manufacturing Practice for Active Pharmaceutical Ingredients Used in Veterinary Drug Products
23 Gen
EU Commission opens participation to Critical Medicines Alliance
<<<3 4 5>>>